Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease.
about
Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA.Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissuesAre blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen.
P2860
Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Characterization of a blood gr ...... patient with Fabry's disease.
@en
Characterization of a blood gr ...... patient with Fabry's disease.
@nl
type
label
Characterization of a blood gr ...... patient with Fabry's disease.
@en
Characterization of a blood gr ...... patient with Fabry's disease.
@nl
prefLabel
Characterization of a blood gr ...... patient with Fabry's disease.
@en
Characterization of a blood gr ...... patient with Fabry's disease.
@nl
P1476
Characterization of a blood gr ...... patient with Fabry's disease.
@en
P2093
Hakomori SI
Wherrett JR
P304
P407
P577
1973-05-01T00:00:00Z